37 results
424B5
MRSN
Mersana Therapeutics Inc
28 Feb 24
Prospectus supplement for primary offering
4:07pm
% of the voting power of our outstanding shares of capital stock, voting together as a single class. This requirement of a supermajority vote to remove … a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of the Company.
Supermajority Approval Requirements
POS AM
MRSN
Mersana Therapeutics Inc
28 Feb 24
Prospectus update (post-effective amendment)
4:05pm
of our outstanding shares of capital stock, voting together as a single class. This requirement of a supermajority vote to remove directors could enable … to elect its own slate of directors or otherwise attempting to obtain control of the Company.
Supermajority Approval Requirements. The DGCL generally
POSASR
MRSN
Mersana Therapeutics Inc
28 Feb 24
Automatic shelf registration (post-effective amendment)
8:43am
as a single class. This requirement of a supermajority vote to remove directors could enable a minority of our stockholders to prevent a change … to obtain control of the Company.
Supermajority Approval Requirements. The DGCL generally provides that the affirmative vote of a majority of the shares
8-K
w6pvcrhawkyq rml81
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:25pm
S-3ASR
t6i1h
9 May 23
Automatic shelf registration
4:10pm
DEFA14A
frbt3
28 Apr 23
Additional proxy soliciting materials
6:02am
424B5
r50p4khg u6vogb13
7 Nov 22
Prospectus supplement for primary offering
4:03pm
424B5
bzfyt mhk
28 Feb 22
Prospectus supplement for primary offering
5:12pm